These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7140136)

  • 1. Comparison of intravenous and oral verapamil dosing.
    Reiter MJ; Shand DG; Pritchett EL
    Clin Pharmacol Ther; 1982 Dec; 32(6):711-20. PubMed ID: 7140136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of verapamil: experience with a sustained intravenous infusion regimen.
    Reiter MJ; Shand DG; Aanonsen LM; Wagoner R; McCarthy E; Pritchett EL
    Am J Cardiol; 1982 Oct; 50(4):716-21. PubMed ID: 7124631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of steady-state verapamil plasma concentrations in children and adults.
    Wagner JG; Rocchini AP; Vasiliades J
    Clin Pharmacol Ther; 1982 Aug; 32(2):172-81. PubMed ID: 7094504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. R-verapamil: pharmacokinetics and effects on PR interval, blood pressure and heart rate.
    Ahmed JH; Godden J; Meredith PA; Elliott HL
    Br J Clin Pharmacol; 1993 Aug; 36(2):93-8. PubMed ID: 8398588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacology of verapamil. IV. Kinetic and dynamic effects after single intravenous and oral doses.
    McAllister RG; Kirsten EB
    Clin Pharmacol Ther; 1982 Apr; 31(4):418-26. PubMed ID: 7060323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of d,l-verapamil on atrioventricular conduction in relation to its stereoselective first-pass metabolism.
    Echizen H; Vogelgesang B; Eichelbaum M
    Clin Pharmacol Ther; 1985 Jul; 38(1):71-6. PubMed ID: 4006378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verapamil disposition and cardiovascular effects in elderly patients after single intravenous and oral doses.
    Carosella L; Menichelli P; Alimenti M; Zuccala G; Gemma A; Cocchi A; Carbonin PU
    Cardiovasc Drugs Ther; 1989 Jun; 3(3):417-25. PubMed ID: 2487538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verapamil disposition kinetics in chronic atrial fibrillation.
    Kates RE; Keefe DL; Schwartz J; Harapat S; Kirsten EB; Harrison DC
    Clin Pharmacol Ther; 1981 Jul; 30(1):44-51. PubMed ID: 7237897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of verapamil on P-R-intervals in relation to verapamil plasma levels following single I.V. and oral administration and during chronic treatment.
    Eichelbaum M; Birkel P; Grube E; Gütgemann U; Somogyi A
    Klin Wochenschr; 1980 Sep; 58(18):919-25. PubMed ID: 7206587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacology of verapamil. I. Elimination kinetics in dogs and correlation of plasma levels with effect on the eletrocardiogram.
    McAllister RG; Bourne DW; Dittert LW
    J Pharmacol Exp Ther; 1977 Jul; 202(1):38-44. PubMed ID: 874818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of two formulations of verapamil.
    Hla KK; Henry JA; Latham AN
    Br J Clin Pharmacol; 1987 Nov; 24(5):661-4. PubMed ID: 3435694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic profile of verapamil in relation to absolute bioavailability: investigations with a conventional and a controlled-release formulation.
    Harder S; Thürmann P; Siewert M; Blume H; Huber T; Rietbrock N
    J Cardiovasc Pharmacol; 1991 Feb; 17(2):207-12. PubMed ID: 1709224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of verapamil following sublingual and oral administration to healthy volunteers.
    John DN; Fort S; Lewis MJ; Luscombe DK
    Br J Clin Pharmacol; 1992 Jun; 33(6):623-7. PubMed ID: 1389935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of food on the pharmacokinetics and electrocardiographic effects of sustained release verapamil in normal subjects.
    Hoon TJ; McCollam PL; Beckman KJ; Hariman RJ; Bauman JL
    Am J Cardiol; 1992 Oct; 70(11):1072-6. PubMed ID: 1414906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the pharmacokinetics and electrocardiographic effects of sublingual and intravenous verapamil.
    Berk SI; Beckman K; Hoon TJ; Hariman RJ; Hu D; Siegel FP; Bauman JL
    Pharmacotherapy; 1992; 12(1):33-9. PubMed ID: 1549537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Near-total reduction in verapamil bioavailability by rifampin. Electrocardiographic correlates.
    Barbarash RA; Bauman JL; Fischer JH; Kondos GT; Batenhorst RL
    Chest; 1988 Nov; 94(5):954-9. PubMed ID: 3180898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verapamil pharmacodynamics after intravenous and oral dosing: theoretic consideration.
    Colburn WA; Brazzell RK; Holazo AA
    J Clin Pharmacol; 1986 Jan; 26(1):71-3. PubMed ID: 3950053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent influences of the structurally dissimilar calcium entry blockers, diltiazem and verapamil, on thyrotropin- and gonadotropin-releasing hormone-stimulated anterior pituitary hormone secretion in man.
    Veldhuis JD; Borges JL; Drake CR; Rogol AD; Kaiser DL; Thorner MO
    J Clin Endocrinol Metab; 1985 Jan; 60(1):144-9. PubMed ID: 3880562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation by dietary salt of verapamil disposition in humans.
    Darbar D; Fromm MF; Dell'Orto S; Kim RB; Kroemer HK; Eichelbaum M; Roden DM
    Circulation; 1998 Dec; 98(24):2702-8. PubMed ID: 9851956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related changes in the pharmacodynamics of verapamil.
    Arnold TH; Vallner JJ; Tackett RL
    Am Heart J; 1985 Nov; 110(5):981-5. PubMed ID: 4061274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.